exhibit 10. 2 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ technical know - how license agreement _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ between fulgent genetics, inc. and fujian fulgent gene biotech co., ltd. no. : fulgent201611 - 9 date : april 25, 2017 this technical know - how license agreement ( hereinafter referred to as “ this agreement ” ) is concluded by the following parties in shenzhen, the people ’ s republic of china ( hereinafter “ prc ” ) on april 25, 2017 : party a : fulgent genetics, inc. ( hereinafter referred to as “ party a ” or “ licensor ” ) add. : 4978 santa anita ave. temple city, ca, 91780 authorized representative : ming hsieh party b : fujian fulgent gene biotech co., ltd. ( hereinafter referred to as “ party b ” or “ licensee ” ) add. : 4f01b, plant 10 #, zone c, 9 maoling road, xindian town, jin ’ an district, fuzhou city, fujian province legal representative : wei xianshu party a and party b are hereinafter referred to as “ parties ” jointly or “ a party ” individually. whereas, 1. party a is the clia and cap certified clinical molecular diagnostic gene testing service organization, with independent research and development of bio - information analysis technology, genetic database, top technical equipment and years of genetic information interpretation experience, providing the world's users with most comprehensive high precision genetic testing services. party b intends to carry out clinical molecular diagnostic genetic testing business in prc ( excluding hong kong, macao and taiwan regions ). 1. 1. party a is the clia and cap certified clinical molecular diagnostic gene testing service organization, with independent research and development of bio - information analysis technology, genetic database, top technical equipment and years of genetic information interpretation experience, providing the world's users with most comprehensive high precision genetic testing services. party b intends to carry out clinical molecular diagnostic genetic testing